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introduction
Peripheral Arterial Disease (PAD) is commonly caused by atherosclerosis of peripheral arter-
ies. The prevalence of PAD is 3-10% in the modern population, and ranges up to 15-20% 
in the elderly population.1-3 Patients with PAD can be treated either with exercise therapy, 
or with revascularization. In patients with critical limb ischemia there is an indication for a 
revascularization procedure, which can be performed by either a percutaneous transluminal 
angioplasty (PTA) or, when this is not possible (because of technical limitations, patient’s co 
morbidities or lesion anatomy), by peripheral bypass surgery. Main outcomes of surgical 
vascular interventions include (graft) patency, limb salvage and surgery related morbidity 
and mortality.4
The graft of choice in peripheral bypass surgery is the autologous saphenous vein (ASV). 
However, a number of patients do not have a good quality ASV available to be used as a pe-
ripheral bypass graft 5, 6. In these patients, there is a need for an alternative for the ASV graft. 
Commonly used prosthetic conduits are grafts made of expanded polytetrafluoroethylene 
(ePTFE). Patency rates of supragenicular ePTFE bypass grafts are comparable to autologous 
bypass grafts 7-9. In contrast, ePTFE infragenicular and femorocrural bypass grafts perform 
worse than venous bypass grafts.
Refinements in the graft design, such as the addition of a venous Miller cuff or a St Mary 
booth at the distal anastomosis, have been advocated to improve the results of a prosthetic 
graft 10. Alternatively, pre-cuffed ePTFE grafts were developed, which have specially designed 
cuff at the distal anastomosis, thereby optimizing flow. These grafts have comparable pa-
tency rates as ePTFE grafts with a venous cuff. 11
As little is known on performance off these pre-cuffed grafts in the normal PAD population, 
we conducted a study to analyze pre-cuffed PTFE graft performance.
New techniques are also developed for the proximal anastomoses in addition to improve-
ments on the distal anastomoses of peripheral bypass surgery.
The standard technique used for the proximal anastomosis in peripheral arterial surgery is 
with running monofilament non-resorbable sutures. Since 1997 there is a commercially avail-
able alternative technique, with non-penetrating titanium clips. The Vessel Closure System 
(VCS, Le Maitre Vascular Inc., Burlington, USA), has proven to increase patency of anastomo-
ses in vascular access surgery. The use of the VCS system has also been advocated because of 
decreased anastomotic time, and its ease of use. 12 This could shorten clamping time of the 
artery and reduce per-operative limb ischemia.
In vitro research showed that the use of non-penetrating clips resulted in improved para-
anastomotic compliance and reduction of intimal damage, compared with sutures. 13 There-
fore, the use of clips for proximal anastomoses in vascular reconstructive surgery might help 
preserve endothelial function and structural integrity and could result in increased patency 
rates. There is very little known on performance of clipped anastomoses in PAD population 
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on the femoral arteries. Therefore we conducted a pilot study to assess the VCS safety in 
femoral artery anastomosis.
However main outcomes remain important, Quality of life (QoL) is increasingly considered 
a contributing outcome measurement of vascular interventions. It is an individual assessment 
of physical, psychological and social well-being that is based on the definition of health by 
the World Health Organization (WHO). 14 QoL incorporates a patient’s individual perception 
of its disease and functioning. 15
Patients suffering from PAD, who are not receiving treatment, cope with a deprived health 
status and QoL due to the effects of the disease and co morbid conditions.15 However, im-
provements in both health status and QoL following peripheral bypass surgery have been 
observed at three months of follow-up. 16 We conducted a review of the literature to analyze 
QoL after vascular interventions, and analyzed midterm QoL scores in one of our previous 
study populations.
As the treatment of PAD is multidimensional and time consuming, an increasing number 
of vascular surgery units expand their care-teams with certified vascular Nurse Practitioners 
(NPs). These NPs have more time for each patient compared to the vascular surgeon. They 
work closely with a supervising vascular surgeon and assist in the multidimensional approach 
of patients’ treatment and reducing and treating risk factors. The NPs follow up on patients 
and guides patients through treatments, for outpatient and inpatient care.17 This could result 
in higher QoL scores, and lower anxiety and depression scores in patients guided by NPs. As 
there are no previous reports on QoL, anxiety and depression scores in patients guided by 
a vascular NP, we decided to study these effects in our vascular population before and after 
adding vascular NPs to our care team.
Every surgical interventions has a risk for complications. Some of these complications can be 
avoided, other complications can be diminished by optimal care taking.
For all complications, a reliable registration is very important. Registering complications 
gives an insight in the incidence and can show patterns of complications. These data could 
be used for diminishing the number of complications. The Dutch Association of Surgeons 
(ASN) has developed a national standardized system for the registration of complications to 
produce reliable information on surgical outcome and create a benchmark. 18 Complications 
are real time documented in this system by the physician who diagnoses the event. This 
form of registration is questioned by different authors for efficiency and objectivity.19 One 
of the possible complications after surgery are surgical site infections, which are registered 
by surgeons or residents. Another way to register complications (in this case, surgical site 
infections) is by specially trained infection control nurses, of the department of medical 
microbiology, who have no direct connections to a surgical department. With the growing 
interest on the occurrence of complication, there is a need for determining the most reliable 
registration method.
11
Introduction
In vascular surgery, surgical site infections are one of the most frequent diagnosed compli-
cations. A deep seated surgical site infection in vascular surgery can, with use of prosthetic 
grafts, lead to high morbidity and even be fatal. Decreasing the number of surgical site infec-
tions is therefore necessary.
Staphylococcus aureus nasal carriage increases a patient’s risk for developing a health 
care-associated infection with this micro organism, at least after cardiac surgery, ortho-
pedic surgery and in peritoneal dialysis. 20-24 Preoperative screening for nasal carriage and 
subsequent treatment of carriers with mupirocin and chlorhexidine reduces the risk for the 
development of hospital-acquired S. aureus infections by 79% for deep-seated infections and 
55% for superficial infections. 25 Consequently, the mean duration of hospital stay is reduced 
in treated carriers by approximately 2 days. A cost benefit analysis shows that the strategy is 
cost-effective and saves lives. 26
In vascular surgery little is known about the relation between nasal carriage of S. aureus 
and surgical site infections (SSI).
thesis outline
The aims of this studies were to analyze both classic and modern outcomes in vascular 
surgery. Classic outcomes are; patency rates (primary, primary assisted and secondary), limb 
salvage and survival. Modern outcomes are; Quality of Life, the registration of complications, 
and new insights to diminish complications. Various clinical studies were performed to ana-
lyze these interests.
In chapter 2, we report patency rates, limb salvage rates and survival after peripheral 
bypass surgery with both autologous, as the new designed ePTFE (expanded polytetrafluo-
roethylene) pre-cuffed bypass graft. This graft has an especially designed cuff at the site 
of the distal anastomosis. The distal cuff has been advocated to increase patency rates by 
optimizing flow at the distal anastomosis, thereby increasing patency rates.
chapter 3 presents our results of a pilot-study, assessing the safety and usability of the use 
of vascular clips in the construction of the proximal anastomosis. This technique is proven to 
be effective in the anastomosis in AV access surgery. We performed a randomized study to 
how these clips performed in the proximal anastomosis in peripheral vascular surgery.
In chapter 4, the literature will be reviewed concerning Quality of Life after treatment for 
peripheral arterial disease. We reviewed literature about QoL after walking exercise, percuta-
neous transluminal angioplasty, revascularization surgery and lower leg amputation.
chapter 5 contains our results for mid-term (> 2 years) follow-up on QoL after peripheral 
vascular bypass surgery. In chapter 6, the effect of certified vascular Nurse Practioners (NPs) 
was studied on patients’ QoL, anxiety and depression scores. We compared to groups, one 
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group with patients who were guided trough treatment by a vascular surgeon, and one 
group of patients who were informed and guided by NPs.
chapter 7 reports on reliability of the registration of complications after vascular surgery. 
We compared two different database which registered surgical site infections (SSI’s) after 
vascular surgery. One database was maintained by the surgical department. The other was 
maintained by infection control nurses from the department of Medical Microbiology. After 
comparing both databases an optimal registration program is described.
In an effort to establish improvement in the occurrence of SSI’s after vascular surgery, we 
performed a study to analyze the relation between Staphylococcus aureus nasal carriage and 
SSI’s. These results are presented in chapter 8.
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abstract
Introduction
The graft of choice in lower limb bypass surgery is the autologous saphenous vein (ASV). 
However, a prosthetic graft is needed in the absence of an ASV. In such situations we used an 
ePTFE pre-cuffed Dynaflo® graft as supragenicular bypass or Distaflo® graft as infragenicular 
or femorocrural bypass. In respect to expanding possibilities of PTA (Percutaneous Translu-
minal Angioplasty), the indication for bypass surgery moved towards patients with advanced 
stages of peripheral arterial occlusive disease. For this reason, this study analyzed the current 
performances of these ePTFE  grafts and ASV grafts with special attention to limb salvage.
Methods
In a retrospective study all patients were included who underwent peripheral bypass surgery 
between 2004 and 2008. Kaplan-Meier curves were used to express primary patency, second-
ary patency and limb salvage rates at one and three years. Log-rank tests were performed to 
compare graft types.
Results
A total of 272 grafts (ePTFE/ASV:110/162) were performed in lower limb bypass surgery. The 
mean follow-up was 20,3 months. The secondary 3-year patency rates were: for 78 suprage-
nicular grafts (ePTFE/ASV:45%/94%)*, for 124 infragenicular grafts, (24%/74%)* and for 70 
femorocrural grafts (26%/52%).
Limb salvage after 3 year was in the ePTFE group 59% vs ASV 78%.* (* p < 0,05)
Conclusion
In the current population of vascular patients where no PTA is possible and a peripheral 
bypass is necessary, the ASV remains the graft of first choice. However the pre-cuffed  ePTFe 
graft is a good alternative, especially in cases of critical limb ischemia, in respect to an accept-
able limb salvage rate.
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introduction
Selected patients suffering from severe peripheral arterial disease (PAD) might be treated 
with a peripheral bypass reconstruction. The graft of choice in lower limb bypass surgery 
is the autologous saphenous vein (ASV). However, a number of patients do not have good 
quality ASV available to be used as a peripheral bypass graft 1, 2. In these patients, there is a 
need for an alternative for the ASV graft. Commonly used prosthetic conduits are graft made 
of expanded polytetrafluoroethylene (ePTFE). Patency rates of supragenicular ePTFE bypass 
grafts are comparable to autologous bypass grafts 3-5. In contrast, ePTFE infragenicular and 
femorocrural bypass grafts perform worse than venous bypass grafts.
Refinements in the graft design, such as the addition of a venous Miller cuff or a St Mary 
booth at the distal anastomosis, have been advocated to improve the results of prosthetic 
graft 6. Alternatively, Pannerton et.al. showed that pre-cuffed ePTFE grafts have comparable 
patency rates as ePTFE grafts with a venous cuff. 7
In previously performed studies, including a randomized controlled trial, the patency rates 
of supragenicular positioned ePTFE and ASV grafts were compared to each other during the 
first two years 1, 2. Since then, enhancements in technology such as the widespread introduc-
tion of percutaneous transluminal angioplasty (PTA) procedures, resulted in further reticence 
to construct a peripheral bypass. As a consequence, nowadays the indication for bypass 
surgery moves towards patients who suffer from advanced stages of PAD and who might 
cope with a compromised distal runoff. The effects of within patient population changes on 
the performance of peripheral bypasses is unknown.
We preferably use the ASV as the graft of choice in patients suffering from severe PAD in 
our hospital. In case of an absent ASV to be used as bypass graft, we currently use the ePTFE 
pre-cuffed Dynaflo® graft for supragenicular femoropoliteal bypass (SFPB)  reconstructions 
and the Distaflo® for infragenicular femoropopliteal bypass (IFPB) and femorocrural bypasses 
(FCB) reconstructions.
The aims of this study were to analyze performance of ePTFE and ASV grafts in patients 
suffering from severe PAD at one and three years after surgery with special attention for limb 
salvage.
Methods
Study design
A retrospective review was undertaken of the medical charts of all patients who underwent 
peripheral bypass surgery. All considered charts were from patients operated on between 
2004 and 2008 due to severe PAD. The variables entered into a dataset were: baseline charac-
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teristics including the Rutherford class, gender, age, smoking status and the presence of dia-
betes and associated co morbid conditions. In addition previous vascular interventions and 
data from the surgical work up were recorded. The revascularization related data included 
graft type and the position of the distal anastomosis. Follow up data consisted of all patency 
related information from the medical charts such as physical examinations, medical imaging 
and laboratory results.
Patients
Two groups of patients were considered by type of bypass. The groups consisted of patients 
who were revascularized either with pre-cuffed ePTFE bypass graft, or with an ASV bypass 
graft. Patients who had a missing ipsilateral ASV, were revascularized using the contralateral 
saphenous vein or the lesser saphenous vein if possible. The brachial veins however, were not 
considered to be used as a bypass graft.
Surgical work up
Prior to surgery, the vascular assessment included an ankle-brachial pressure index (ABI), a 
treadmill test, a venous and arterial duplex ultrasound (US) assessment and either a digital 
subtraction angiography (DSA) or a magnetic resonance angiography (MRA) scan. Patients 
were considered for pre-cuffed ePTFE graft if both ipsilateral and contralateral ASV, or the 
lesser saphenous veins were absent of unsuitable to be used as an autologous bypass graft. 
Judgment was based on a preoperatively performed ultrasound evaluation8 or on findings 
following an open operative exploration if the ultrasound assessment was inconclusive.
Surgical procedure
Surgery was performed under general and/or spinal anesthesia. An autologous bypass was 
constructed using either a deep-tunneled reversed or an in-situ technique. A pre-cuffed 
ePTFE Dynaflo® (Bard Peripheral Vascular Inc., Tempe, AZ, USA) graft was used if the distal 
anastomisis was situated supragenicularily while a pre-cuffed Distaflo® (Bard Peripheral Vas-
cular Inc., Tempe, AZ, USA) was used if the distal anastomosis was situated infragenicularily. 
All grafts were inplanted end-to-side. A routine Doppler assessment was performed before 
closure of surgical wounds. Patients underwent systemic heparinazation (5000 IE) during the 
operation.
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Post-operative course and follow up
Oral anticoagulant administration (acenocoumarol) was initiated for a two year period or 
resumed post-operatively following autologous bypass surgery with a target International 
Normalized Ratio (INR) between 2.5 and 3.5 during the first two post-operative years9, 10. The 
use of acetylsalicylic acid (ASA) was initiated or continued postoperatively in patient who 
received an ePTFE graft (80mg daily). All follow-up examinations included an assessment of 
the distal pulses during interval visits. Patients with ASV grafts were routinely checked with 
Duplex US and an ABI at three months and at six months, followed by an ABI at two years. 
The follow up of patients with an ePTFE graft was restricted to a single Duplex US and ABI at 
three months, followed by an ABI at one and at three years. A Duplex US was performed as 
well on suspicion of graft related problems (such as the absence of pulses or deterioration in 
ABI) in all patients.
Statistical analysis
Patency was defined in conformity with the guidelines by Rutherford et al.11 The last moment 
a graft was considered patent is defined by the last date on which the graft was proven to 
be patent. Beyond the last date of proof of patency the graft was considered lost to follow 
up. Limb salvage was defined as freedom from a major amputation in patients with critical 
ischemia only (Rutherford class 4-6).
Statistical analysis was performed with SPSS 16.0 software (SPSS Inc., Chicago, IL, USA). 
Kaplan-Meier curves were used to express primary, primary assisted, secondary patency and 
limb salvage. These patency rates were calculated for supragenicular, infragenicular and 
femorocrural bypasses individually in both groups, as well as for limb salvage. In addition, 
due to imbalances at baseline of the revascularization indication, per Rutherford class pa-
tency rates were calculated.
Log rank tests were used to compare the results. A P value <0.05 was considered to show 
a significant difference.
results
A total of 272 grafts were used in revascularization of patients with peripheral bypass surgery 
in our hospital between 2004 and 2008. This consisted of 162 grafts of the ASV, while 110 
grafts were  a pre-cuffed ePTFE graft. In table 1, the baseline characteristics are listed. In 
addition the positions of the distal anastomosis are listed as well as the number of redo 
operations. Based on the Rutherford class, patients who underwent ePTFE peripheral bypass 
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surgery were affected more seriously than patients who underwent autologous bypass 
surgery.
As many ASV bypasses as pre-cuffed ePTFE bypasses were constructed supragenicularily. 
The ASV was used as a bypass graft in the majority of cases for infragenicular and femorocru-
ral reconstructions. Table 2 shows a listing of the type of bypass used at each location.
Table 1. Baseline and surgical characteristics.
Characteristics Pre-cuffed ePTFE group ASV group
N 110 162
Sex, Male/Female (%) 70/40 (63.6/36.4) 116/46 (71.6/29.4)*
Age average (range) 71.8 (36.8-96.6) 69.1 (41.0-86.4)
Diabetes (%) 39 (35.5) 61 (37.9)
History of recent smoking (%) 56 (50.9) 82 (50.9)
Hypertension (%) 65 (61.9) 80 (52.6)*
Indication for revascularization (Rutherford Class)
2 (%) 3 (2.8) 3 (1.9)
3 (%) 21 (19.4) 56 (34.6)*
4 (%) 46 (42.6) 46 (28.4)*
5,6 (%) 38 (35.2) 57 (35.2)
Location of distal anastomosis
Supragenicular (%) 39 (35.5) 39 (24.1)
Infragenicular (%) 43 (39.1) 81 (50.0)
Femorocrural (%) 28 (25.5) 42 (25.9)
Primary/Redo (%) 83/27 (75.5/24.5) 145/17 (89.5/10.5)*
* Denotes a significant difference between ePTFE and ASV (P< 0,05)
Table 2. Percentage pre-cuffed ePTFE bypasses vs total performed bypasses.
Characteristics Pre-cuffed ePTFE group ASV group
Supragenicular (%) 39 (50%) 39 (50%)
Infragenicular (%) 43 (35%) 81 (65%)
Femorocrural (%) 28 (40%) 42 (60%)
Patency rates
All 1-year and 3-year patency rates, of both supragenicualar and infraganicular femoropop-
liteal and femorocrural bypass surgery are listed in Table 3. One-year and 3-year primary pa-
tency rates of supragenicular bypass were almost equal. However, significantly better 1-year 
and 3-year primary assisted and secondary patency rates of supragenicular ASV grafts 
were found in comparison to ePTFE grafts.  All patency rates of autologous infragenicular 
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femoropoliteal bypasses were superior to corresponding ePTFE bypasses. No signifi cant dif-
ferences in patency rates could be detected between autologous and ePTFE femorocrural 
bypasses. However, a tendency of higher patency rates of autologous grafts was seen. Sec-
ondary patency rates of supragenicular and infragenicular bypasses, as well as patency rates 
of femorocrural bypasses are plotted in Figure 1 to 3. All signifi cant diff erences maintained in 
a per Rutherford class analysis of patency rates.
Table 3. Patency rates.
Characteristics Pre-cuff ed ePTFE group ASV group
Mean follow up, months (range) 19.9 (<1–64.7) 20.5 (<1–63.3)
Distal anastomosis Patency 1-year 2-year 3-year 1-year 2-year 3-year
Supragenicular
Primary (%) 57 47 47 63 57 57
Primary Assisted (%) 57 47 47 94* 94* 94*
Secondary (%) 63 52 45 94* 94* 94*
Infragenicular
Primary (%) 34 13 13 63* 61* 55*
Primary Assisted  (%) 36 20 20 78* 75* 75*
Secondary (%) 40 24 24 81* 74* 74*
Femorocrural
Primary (%) 28 28 19 42 42 42
Primary Assisted (%) 28 28 19 42 42 42
Secondary (%) 38 26 26 52 52 52
Limb salvage (%) 68 59 59 85* 78* 78*
*Denotes a signifi cant diff erence between ePTFE and ASV (P< 0,05)
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Figure 1) Kaplan-Meier curves representing secondary patency rates of supragenicular femoropopliteal bypasses.
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Figure 2) Kaplan-Meier curves representing secondary patency rates of infragenicular femoropopliteal bypasses.
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Figure 3) Kaplan-Meier curves representing secondary patency rates of femorocrural bypasses.
Limb salvage
One-hundred-eighty-six of a total of  272 grafts, were implemented in patients (ePTFE/
ASV:84/102) who suff ered from chronic critical ischemia (Rutherford class 4-6). A signifi cantly 
higher limb salvage rage was achieved in patients who underwent autologous bypass sur-
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gery (Figure 4). These signifi cant diff erence also maintained in a per Rutherford class analysis 
of limb salvage. The pre-cuff ed ePTFE limbsalvage rates are 68 % after one year of surgery, 
and 59% after three years of surgery.
Cu
m
ul
at
iv
e 
Su
rv
iv
al
1,0
0,8
0,6
0,4
0,2
0,0
Months
60483624120
ePTFE      48               30                                  17                                   9
ASV          64               46                                  25                                 18
Limb Salvage
Page 1
Figure 4) Kaplan-Meier curves representing limb salvage.
discussion
The autologous vein still off ers superb performances in peripheral bypass surgery in com-
parison to prosthetic conduits. In this study patency rates of both autologous and ePTFE 
peripheral bypass grafts were compared to each other. Especially infragenicular autologous 
bypasses performed signifi cantly better than ePTFE grafts. Performances of autologous grafts 
were comparable to previously performed studies1, at least for secondary patency. A 77% 
2-year secondary patency rate for supragenicular autologous bypass grafts was reported 
meta-analysis performed by Klinkert et.al.1
Alternatively, prosthetic grafts can be used in the absence of a suitable vein to be uses as 
a bypass graft. Over the years several artifi cial graft types were introduced, such as Dacron 
and ePTFE. In the meta analysis performed by Roll et all, nine randomized controled trials 
were included to analyze the performance of Dacron versus PTFE grafts 12. No signifi cant 
diff erences could be detected between primary patency of both graft types.
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One of the explanations for lower PTFE patency rates was the mismatch in compliance 
between the relatively stiff prosthetic graft and the native artery. In combination with 
iatrogenic injury caused by suturing the anastomosis, this is thought to induce neointimal 
hyperplasia and therefore stenosis at the distal anastomosis. Enhancements in cuff-design 
led to improvement of prosthetic graft performance. Miller described the first widely used 
vein cuff in 1984, which improved patency results from 29% to 57% after three years. 13
Similar results have been achieved by the Taylor patch and St. Mary´s boot. This all led to 
the development of a pre-cuffed (e)PTFE graft, which performance was comparable with a 
venous cuffed (e)PTFE. 7
However, ePTFE patency rates from this study underperformed in comparison to other 
recently published studies. This study´s infragenicular and femorocrural patency and limb 
salvage results, compared to literature are listed in table 4.
In both this and the study by Gulkarov et.al.14, a large percent of patients were included 
who suffered from chronic critical ischemia. However, in the latter study superb patency rates 
are presented compared to ours. A possible explanation could be, that we analyzed bypass 
performances rather than patients. Several patients are thus included double as illustrated 
by the redo bypass procedures. Another explanation could be that we set very strict patency 
definitions, based on Rutherford et.al. 11, to determine graft patency.
Only a small number of femorocrural bypasses were included in this study. As a conse-
quence, we could not prove the superiority of the ASV graft over the ePTFE graft. In the 
absence of alternatives, performing pre-cuffed ePTFE femorocrural bypass surgery can be 
considered justifiable.
When we compare our pre-cuffed ePTFE results to other grafts, like the Heparin bounded 
ePTFE graft, the Heparin bounded grafts show higher patency rates.
Table 4. Reported patency rates of infragenicular ePTFE Distaflo® bypasses by this study and previous studies.
1-year patency rates
1-year limb 
salvage (%) Study
Reference
Nr. N (Nc) Follow up (months) Primary (%) Secondary (%)
Femorocrural 
primary (%)
Alcocer et al 16 35 (30) 15.2 51 53 nr 75
Fisher et al 17 (30b) 10.4 39 nr 20b 50
Panneton et al 7 47 (35) 14 52 53 nr 72
Bellosta et al 18 12 (12) 22.5 nr 31c 31c nr
Oderich et al 19 40 (25) 25.7 70 nr nr 97
Gulkarov et al 14 52 (24) 12 65.1 80.4 44.4 (63.2d) 85.3
Donker et al — 71 (28) 19.9 31.5 39.1 28 (38d) 67.6
N = number of Distaflo® bypasses, Nc = number of femorocrural Distaflo® bypasses, nr = not reported, b study reports patency data only for 20 
femorocrural Distaflo® bypasses, c 4-year secondary patency, d secondary patency.
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Daenens et.al study showed very impressive patency rates with Heparin bounded synthetic 
bypasses 15, however their study contains very few autologous grafts, so in our opinion their 
results are hard to compare to our results.
For patients who require a peripheral bypass, but who do not have a suitable ASV or other 
vein to be used as bypass, a pre-cuffed ePTFE bypass offers reasonable alternatives. Also 
there is a fairly acceptable limb salvage rate for pre-cuffed ePTFE bypasses.
conclusion
The ASV remains the bypass of first choice, because of the higher patency rates and better 
limb salvage. However, in patients in whom the autologous saphenous vein is absent or 
unsuitable, the pre-cuffed ePTFE graft seems to be an appropriate alternative.
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abstract
Introduction
The Vessel Closure System is commercially available since 1997. This clip system has proven 
to be successful for vascular anastomoses in access surgery. There is little experience with the 
VCS in peripheral vascular surgery.
Materials and Methods
A trial was performed for patients with peripheral arterial disease, which required either a 
femoral artery endarterectomy or a peripheral bypass procedure. Patients were randomized 
in two groups; a VCS group, in which the proximal anastomoses were made with VCS clips 
and a control group in which both anastomoses were made with prolene. Outcomes were; 
speed of anastomosis and patency. Adverse events were monitored.
Results
In the VCS group, 12 patients received VCS clips. In the control group, 12 patients underwent
vascular reconstruction with sutures. In the VCS group the mean speed of anastomosis 
was 1.9 mm/min, where the mean speed in the control group was 2.5 mm/min. This was not 
significantly different. (P = 0.096). After a follow-up of 12 months, there was no difference in 
patency. In the VSC group, two serious adverse events took place which required emergency 
surgery.
Conclusion
The use of VCS in anastomosis in the femoral artery is not faster than running prolene sutures 
and in our small sample size, two serious adverse events in the VCS group were observed. 
These results do not support the further use of vascular clips in peripheral vascular surgery.
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introduction
The standard technique used for the anastomosis in peripheral arterial surgery is with run-
ning monofilament non-resorbable sutures. Since 1997 there is a commercially available 
alternative technique, with non-penetrating titanium clips. The Vessel Closure System (VCS, 
Le Maitre Vascular Inc., Burlington, USA), has proven to increase patency of anastomoses in 
for vascular access surgery.1 The use of the VCS system has also been advocated because of 
decreased anastomotic time, and its ease of use.1 This could shorten clamping time of the 
artery and reduce per-operative limb ischemia.
In vitro research showed that the use of non-penetrating clips resulted in improved 
para-anastomotic compliance and reduction of intimal damage, compared with sutures. 2 
Therefore, the use of clips for vascular anastomoses might help preserve endothelial function 
and structural integrity.
Because results in access surgery are positive, and results in peripheral arterial surgery are 
limited, we started a pilot study on the use of vascular clips in patients with peripheral arterial 
disease.
The aim of this study was to compare the VCS with running monofilament sutures in femo-
ral anastomoses in patients who required either a femoropopliteal bypass graft, or a femoral 
artery endarterectomy and a vascular patch.
Methods
Study Design
Patients with Rutherford stage 3 or more, who were planned to undergo either a peripheral 
bypass or a femoral artery endarterectomy were recruited from our outpatient clinic. They 
were randomized between  the VCS system and sutured anastomosis. Between 2009 and 
2010 we planned to include 20 patients in the pilot study. While the trial was running, there 
was some early loss to follow-up because of early mortality not caused by surgery. For this 
reason we adjusted the inclusion to 24 patients in order to maintain a reasonable number of 
anastomoses to analyze during one year.
Randomization was performed by a closed envelope system, after patients signed a writ-
ten informed consent agreement.
The primary outcome measure was speed of anastomosis during the operation.
The length of the anastomosis in centimeters and the time it cost to construct the anas-
tomosis with either the VCS clips or with running sutures in minutes were noted in a case 
form by the vascular surgeon. The time of anastomosis was  defined as  the moment of the 
first suture until release of the circulation and  timed by the circulating nurse during surgery.
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The secondary outcome was patency of the bypass or endarterectomy, as defined by Ruth-
erford et al3.
One of our vascular surgeons followed a training for the use of the VCS clip applier, this 
surgeon trained our other surgeons on handling of the VCS.
Surgical work up
Prior to surgery, the vascular assessment included an ankle-brachial pressure index (ABI), 
a treadmill test, a venous screening by duplex ultrasound (US) assessment and a magnetic 
resonance angiography (MRA) scan.
Surgical procedure
Surgery was performed under general and/or spinal anesthesia. An autologous bypass was 
constructed using a deep-tunneled reversed or an in-situ technique. In case the autologous 
saphenous veins were absent, or inadequate, a pre-cuffed ePTFE Dynaflo® (Bard Peripheral 
Vascular Inc., Tempe, AZ, USA) graft was used if the distal anastomosis was situated above the 
knee while a pre-cuffed Distaflo® (Bard Peripheral Vascular Inc., Tempe, AZ, USA) was used if 
the distal anastomosis was situated below the knee. All grafts were implanted end-to-side in 
the femoral artery.
A femoral artery endarterectomy was performed by an longitudinal arteriotomy. The defect 
in the femoral artery was closed with a bovine pericardium patch. (Vascu-Guard, Biovascular 
Inc., Saint Paul, MN, USA)
In the VCS group, the proximal anastomosis, or patch in case of a femoral endarterectomy 
procedure, was made with clips, by using the Vessel Closure System, as advised by the LeMai-
tre and described in Balar et al.4 (Picture 1)
VCS were applied by use of the applicator, all clipped anastomosis were made with size 
Large clips.
The control group received suture closing technique (Prolene, Ethicon, Johnson and John-
son, Somerville, New Jersey, USA) of the proximal anastomosis, or patch in case of a femoral 
endarterectomy procedure.
In case of a distal anastomosis in patients receiving bypass surgery, it was performed with 
running sutures in both groups.
A routine doppler assessment was performed before closure of surgical wounds. Patients 
underwent systemic heparinization (5000 IE) during the operation. After anastomosis 
construction, the anastomosis was visually inspected for several minutes, to evaluate anas-
tomotic bleeding. If necessary an extra suture, or clip in the VCS group, was placed until the 
anastomosis was completely dry. No Heparin antagonists were administered (eg Protamine).
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Post-operative course and follow up
Oral anticoagulant administration (acenocoumarol) was initiated or resumed post-operative-
ly following autologous bypass surgery with a target International Normalized Ratio (INR) 
between 2.5 and 3.5 during the first two post-operative years5, 6. The use of acetylsalicylic 
acid (ASA) was initiated or continued postoperatively in patient who received either an ePTFE 
graft or patients after a femoral artery endarterectomy (80mg daily). All follow-up exami-
nations included an assessment of the distal pulses during interval visits. All patients were 
routinely checked with duplex  ultrasound and an ABI at three months, at six months and at 
one year post surgery.
The  proximal anastomosis was closely monitored with duplex for signs of occlusion or 
stenosis.
Statistical analysis
For all patients, the speed of the proximal anastomosis was calculated, and an independent 
samples t-test was performed. A P-value < 0,05 was considered significant. Statistical analysis 
was performed with SPSS 19.0 software (SPSS Inc., Chicago, IL, USA).
Picture 1. Anastomosis at the Common Femoral Artery, performed with Vascular Clips.
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Ethics
Our study protocol was approved by a regional Medical Ethical Committee, as well as our 
own MEC.
results
Between 2009 and 2010, 24 patients were included. The VCS group consisted of 12 patients, 
10 of whom underwent bypass surgery (9 autologous saphenous vein, 1 ePTFE graft) and 2 
patients underwent a femoral artery endarterectomy.
The control group consisted of 12 patients, 8 of whom underwent a femoral artery endar-
terectomy, and 4 patients underwent bypass surgery (3 autologous saphenous vein, 1 ePTFE 
graft).
The mean age in the VCS group was 73 years (48-83 yr) and in the control group 71 years 
(51-80 yr). (Table I)
In one VCS patient the arterial wall was deemed unfit for clips because of calcification, so 
the surgeon decided to use sutures.
The average speed (mm/min) in the VCS group was 1.9 mm/min, while the average in the 
control group was 2.5 mm/min. This was not a statistically significant difference (P > 0,05). 
(Table II) In the VCS group one patient died after one year of follow-up. There were also three 
occluded bypass grafts in the VCS group. No stenoses were detected in the other anastomo-
ses during follow-up.
In the control group were three deceased patients after one year of follow-up, there was 
also one occluded bypass graft. Mean follow-up was 11.3 months.
Table 1. Baseline characteristics.
Characteristics VCS group Control group
N 12 12
Sex, Male/Female (%) 7/5 (58%) 12/0 (100%)
Age average (range) 73 (48-83) years 71 (51-80) years
Number of bypasses 10 4
Number of Femoral artery endarterectomies 2 8
Rutherford classification
3 2 7
4 5 2
5 and 6 5 3
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None of these deaths were directly related to the performed surgery. Three patients died 
of cardiac failure and possible myocardial infarction. One patient died after an ischemic 
cerebrovascular accident.
In one VCS patient, there was a major complication of a anastomosis rupture because 
of a clip malfunction, which needed a surgical reintervention. This was reported as serious 
adverse event to the medical ethic committee.
One VCS patient needed a surgical reintervention because of an acute thrombosis of the 
superficial femoral artery, one day after femoral artery endarterectomy, because of a distal 
intima laesion, which was not fixed adequately by the placed clips.
discussion
The VCS has been used previously in the creation of vascular anastomoses at different ana-
tomical locations, for access surgery, transplant surgery and in small numbers for peripheral 
vascular surgery1, 4, 7 Multiple studies showed advantages of vascular clips in access surgery1, 
8-14, however the benefits of vascular clips in peripheral arterial surgery is less clear. Several 
small series showed reasonable patency rates when using clips, and a possible faster anasto-
motic time.4, 13, 15 Despite initial promising results, we found no other publications since 2001 
on the subject. In order to improve results of peripheral vascular surgery we hypothesized 
that the VCS could create a  more durable anastomosis than running prolene sutures. Before 
conducting a large randomized control trial, we aimed to establish whether the VCS clips 
were safe and easy in use for anastomoses at the femoral artery, in a pilot study.
We included patients after both peripheral bypass surgery as well as after femoral endarter-
ectomies, because we assumed that the technique of applying an anastomosis at the femoral 
artery, would not differ between both procedures. At least for our outcomes of anastomosis 
speed and patient safety. We are aware that patency rates between both procedures are not 
very comparable.
In this study, three people already had a complete occlusion of their proximal anastomoses 
within one year. The time needed for applying the anastomoses was not significantly dif-
ferent from the control group. However, a faster applied anastomosis means less clamping 
time, the time needed for the anastomosis is still only a part of the complete time of surgery, 
and therefore clamping time is not only dependant on the speed of the anastomosis. Our 
preliminary results did not meet our expectations. Although the initial technical success rate 
Table 2. Anastomosis speed.
Characteristics Control group VCS group
Mean Speed (mm/min) (SD) 2.5 (0.81) 1.9 (0.84)
P-value = 0.096
Chapter 3
38
was high, significant complications occurred in the VCS group that could be attributed to 
the use of clips. The presumed higher speed of anastomosis could not be confirmed. In fact, 
average speed was lower in the VCS group.
There were two serious adverse events in the VCS group; in one patient the clipped anasto-
mosis ruptured, causing  major bleeding from the femoral artery. In another patient an acute 
thrombosis of the superficial femoral artery had occurred. As we could not determine any 
benefits from the use of clips in the proximal anastomosis, we concluded the safety of the 
use of VCS clips in peripheral vascular surgery is not proven, and we will not continue with a 
large randomized control trial.
In conclusion, because of the two serious adverse  events, the costs of the disposable clip 
appliers, and the lack of any positive results of the use of vascular clips, we dispute the safety 
of the use of VCS on the Femoral artery.
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abstract
Introduction
Staphylococcus aureus is the most important pathogen in the development of surgical site 
infections (SSI). Patients who carry S. aureus in the nose are at increased risk for the devel-
opment of SSI in cardiothoracic and orthopedic surgery. In these populations it has been 
shown that the risk for SSI can be substantially reduced by eradicating S. aureus carriage. For 
vascular surgery the relation between nasal carriage and surgical site infections has not been 
clearly investigated. For this reason we performed this study to analyze the relation between 
S. aureus nasal carriage and SSI in our vascular surgery population.
Methods
A prospective cohort study was undertaken, including all patients undergoing vascular 
surgery between January first 2010 and December 31th 2010. Before surgery patients were 
screened for S. aureus nasal carriage using a PCR technique. The presence of SSI was recorded 
based on criteria of the CDC.
Results
Screening was performed in 224. Of those, 55 (24.5%) were positive, 159 (71.0%) were 
negative and 10 (4.5%) were inconclusive. In the screened vascular population 4 S. aureus SSI 
occurred in the 55 carriers compared with 6 in 159 non-carriers (p=0.24). A stratified analysis 
revealed a 10-fold increased risk in nasal carriers undergoing central reconstruction surgery 
(3 S. aureus SSI in 20 procedures versus 1 in 65 procedures in non-carriers, p=0.039).
Discussion
In patients undergoing central reconstruction surgery nasals carriers are at increased risk 
for the development of S. aureus SSI. These patients will probably benefit from perioperative 
treatment to eradicate nasal carriage.
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introduction
Staphylococcus aureus nasal carriage increases a patient’s risk for developing a health care-
associated infection with this micro organism, at least after cardiac surgery, orthopedic sur-
gery and in peritoneal dialysis. 1-5 Preoperative screening for nasal carriage and subsequent 
treatment of carriers with mupirocin and chlorhexidine reduces the risk for the develop-
ment of hospital-acquired S. aureus infections by 79% for deep-seated infections and 55% 
for superficial infections. 6 Consequently, the mean duration of hospital stay is reduced in 
treated carriers by approximately 2 days. A cost benefit analysis shows that the strategy is 
cost-effective and saves lives. 7
In vascular surgery little is known about the relation between nasal carriage of S. aureus 
and surgical site infections (SSI).
For this reason we conducted a prospective analysis of S. aureus nasal carriage in patients 
undergoing vascular surgery and the occurrence of surgical site infections.
Methods
A prospective cohort study was performed on all patients who underwent elective vascular 
surgery between January 1st 2010 and December 31th 2010 in the Amphia Hospital, Breda, 
The Netherlands.
Operations included were; central reconstructions for both abdominal aortic aneurysms 
and occlusive disease (endovascular (EVAR) and open), peripheral bypass procedures (au-
tologous and PTFE), endarterectomies of the femoral and carotid artery, embolectomies and 
Artero-venous access procedures.
Patients were screened on the day that they were admitted to the vascular surgery depart-
ment of the Amphia hospital in Breda. Screening was performed using a dry, sterile swab, 
which was rotated four times in each nostril. The swab was placed in saline and centrifuged. 
Part of the sample was processed for polymerase chain reaction (PCR) on the presence of S. 
aureus, and part was inoculated onto a blood agar plate, to allow nasal and infecting strains 
to be compared in case a surgical site infection did occur.
The GeneXpert MRSA/SA Assay (Cepheid, Sunnyvale, CA) is a real-time PCR-based method, 
which identifies S. aureus and also can differentiate whether a S. aureus is a Methicillin-
susceptible (MSSA) or Methicillin-resistant (MRSA).8-11
Patients were followed prospectively for the development of Surgical site infections (SSI) 
which were defined according to the criteria of the Centers for Disease Control. 12
The main criteria are the presence of: redness, heat, swelling or pain around the wound 
within 30 days after the initial procedure, and the presence of a positive culture, drainage of 
the wound, or pus after a diagnostic puncture. When prosthetic material had been used the 
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follow up was extended up to one year. Infections were differentiated between superficial, 
deep seated and organ based infections.
Screening was performed as part of the infection control strategy of the Amphia hospital us-
ing non-invasive sampling. Approval of the medical ethical committee and informed consent 
were not applicable.
A stratified analysis was performed for patients with central vascular surgery, as we ex-
pected a possible difference for the importance of nasal carriage between patients suffering 
from peripheral arterial occlusive disease (PAOD) and patients suffering from central diluting 
vascular disease.
Patients suffering from PAOD have a gradient of lower limb ischemia, which ranges from 
impaired walking distance, due to inappropriate blood flow to the lower limbs (intermit-
tent claudication), to critical limb ischemia. In those patients hypo perfusion of the lower 
limbs often results in ischemia or even ischemic ulcers. These ulcers may be colonized with 
pathogens, which may be introduced into the surgical wound. This may alter the role of nasal 
carriage as there is an additional source of S. aureus in the patient.
Statistical analyses was performed with SPSS software v 19.0 (SPSS Inc., Chicago, IL, USA), the 
Fisher exact test was used to determine significance.
A multivariate analysis was performed for evaluation of several other known risk factors on 
the development of SSI’s. Chi-square test was used to determine significance.
A P-value <0,05 was considered significant.
results
As shown in table 1, 224 patients were included. There were a total of 17 SSI’s, 13 of which 
were superficial, and 4 where deep seated SSI’s. The PCR of nasal swabs showed that 159 
(71.0%) were negative for S. aureus, 55 (24.6%) were positive and 10 (4.5%) were inconclusive 
because of inhibition of the amplification reaction. In 214 patients with conclusive results, 
there were 16 surgical site infections, 10 of which were caused by S. aureus and 6 by other 
pathogens.
The incidence of surgical site infections in nasal carriers of S. aureus is 4 out of 55 (7.3%), 
whereas the incidence in non-carriers is 6 out of 159 (3.8%)(RR=1.9, 95%CI 0.5-7.5).
A stratified analysis was performed for central reconstruction surgery, peripheral bypass 
surgery and other procedures as shown in Table 2. In peripheral bypass surgery 2 S. aureus 
surgical site infections occurred in patients who did not carry S. aureus (n=45) and no infec-
tions in Patients who carried S. aureus (n=17) (P>0.05).
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In the central reconstruction surgery population, there was 1 surgical site infection in 
patients who did not carry S. aureus (n=65), this SSI occurred after an aortoilliac bypass proce-
dure because of occlusive disease, and there were 3 infections with S. aureus in Patients who 
carried S. aureus (n=20), 1 SSI after an EVAR procedure, 1 SSI after open aneurysm repair and 
1 after an aortoilliac bypass procedure because of occlusive disease (RR=9.8, 95%CI 1.1-88.6, 
P=0.039).
A multivariate analysis including 3 other risk factors known from the literature for the 
development of surgical site infections, did not alter the effect of nasal carriage (Table 3).
Table 1. Baseline and surgical characteristics and surgical site infections caused by S. aureus.
Characteristics
N 224
Sex, Male/Female (%) 171/53 (76.3/23.7)
Age mean (SD) 70 (10.1)
Type of Surgery N/(%) No of SSI’s (%)
No of S. aureus SSI 
(%)
Aortic open repair 52 (23) 6 (11) 3 (6)
Aortic endovascular repair 38 (17) 1 (3) 1 (3)
Femoral endarterectomy 34 (15) 3 (9) 3 (9)
Peripheral bypass surgery
Autologous bypass 42 (66) 2 (5) 1 (2)
PTFE bypass 22 (34) 4 (18) 1 (5)
AV access surgery 14 (6) 0 (0) 0 (0)
Peripheral embolectomy 4 (2) 1 (25) 1 (25)
Carotid endarterectomy 18 (8) 0 (0) 0 (0)
Total 224 (100) 17 (8) 10 (4)
Table 2. Relation between S. aureus carriage and surgical site infections caused by S. aureus.
Surgery type S. aureus SSI-rate (%) RR 95% CI P-value*
Central reconstructions (n=90)
Non-carriers (n=65) 1 (1,5)
Carriers (n=20) 3 (15) 9.8 1.1-88.6 0.039
Inconclusive (n=5)** 0
Other procedures  (n=134)
Non-carriers (n=95) 5 (5)
Carriers (n=35) 1 (3) 0.5 0.1-4.4 0.480
Inconclusive (n=5)** 0
* Fisher exact test; **Inconclusive screening results were not used for analyzation
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discussion
Our study shows that surgical site infections in vascular surgery occur relatively frequent and 
that the majority (62%) are caused by S. aureus. Especially the central reconstructions and 
the peripheral bypass procedures have a relatively high incidence of surgical site infections, 
compared to, for example, carotid endartectomies and AV access procedures.
Overall there is no significant relation between nasal carriage of S. aureus and the occur-
rence of surgical site infections. However, a stratified analysis on patients who underwent ab-
dominal aortic surgery shows a significant association. The effect in this group is comparable 
to what has been found previously in cardiothoracic and orthopedic surgery.1-3, 5
In other vascular procedures no significant effect was found. The infections in this group 
mainly occurred in peripheral procedures of patients with occlusive disease. Patients with oc-
clusive vascular disease cope with insufficient blood flow to at least one of the, mostly lower, 
limbs. This insufficient blood flow is often associated with ischemic disease, e.g. gangrene of 
non healing ulcers. As this wounds can be infected or colonized prior to surgery with a large 
scale of different pathogens, this could limit the role of S. aureus nasal carriage. In our study 
no significant effect after peripheral vascular surgery was found. However, for one patient 
who was positive for S. aureus nasal carriage and who developed a S. aureus SSI, accidently 
a sample of both the nasal swab as well as a wound swab were available for typing. This 
showed that the two trains were identical. Considering the small number of patients and 
the frequent presence of wounds before surgery we consider the role of nasal carriage in 
peripheral vascular surgery unresolved.
All S. aureus strains were methicillin susceptible and no MRSA was found which reflects the 
low rate of MRSA in Dutch hospitals. Also all strains were mupirocin susceptible. Potentially 
administration of mupirocin could reduce the risk of nasal carriage.6 A cost effectiveness 
analysis showed that treating every patient with S. aureus eradication therapy, without 
screening for nasal carriage is the most cost-effective way for preventing surgical site infec-
Table 3. Relation to S. aureus carriage and surgical site infections caused by S. aureus.
S. aureus SSI-rate RR 95% CI P-value
Central reconstruction (n=85)
non-carriers 1/65
carriers 3/20 9.75 0.94-242.31 0.039
Peripheral bypass surgery (n=62)
non-carriers 2/45
carriers 0/17 na na 1.000
Other procedures (n= 67)
non-carriers 3/49
carriers 1/18 na na 1.000
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tions.7 However, as recent studies reported mupirocin resistant MRSA strains13, 14, it should 
only be used in proven MSSA and MRSA carriers to limit the risk for development of further 
resistance.
Based on the results of this study we conclude that S. aureus carriers who undergo central 
reconstructive surgery have a significant higher risk for the development of SSI which can be 
decreased by perioperative eradication of S. aureus in nasal carriers.6
This is important because infection with S. aureus after aortic reconstructions is related to 
severe complications and a high mortality rate.
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general discussion
With the increasing incidence1, 2 of PAD and the further development of minimal invasive 
treatment options, the role of vascular surgery is changing. In contrast to classical outcomes, 
like patency and limb salvage rates, new outcomes are increasing in popularity. In addition, 
new techniques are developed for increasing graft performance. For example, changes on 
the distal anastomosis and new techniques on how to perform a proximal anastomosis.
chapter 2 describes our results from a comparative study on the newly developed pre-
cuffed ePTFE bypass graft. Despite the newly designed distal cuff, the patency rates of the 
autologous grafts, especially for infragenicular bypass grafting, were significantly better 
compared with the pre-cuffed ePTFE grafts. So, the autologous vein still offers superb per-
formances in peripheral bypass surgery in comparison to prosthetic conduits. For patients 
who require a peripheral bypass, but who do not have a suitable ASV or other vein to be used 
as bypass, a pre-cuffed ePTFE bypass offers reasonable alternatives. Also there is a fairly ac-
ceptable limb salvage rate for pre-cuffed ePTFE bypasses. When we compare our pre-cuffed 
ePTFE results to other grafts, like the Heparin bounded ePTFE graft, the Heparin bounded 
grafts show higher patency rates.
Daenens study showed very impressive patency rates with Heparin bounded synthetic 
bypasses 3, however their study contains very few autologous grafts, so in our opinion their 
results are hard to compare to our results. For determining the optimal non autologous graft 
in peripheral bypass surgery, a prospective trial comparing both the pre-cuffed ePTFE grafts 
and the Heparin bounded grafts is necessary.
A new technique for the proximal anastomosis is investigated in chapter 3. The use of 
non-penetrating, titanium clips in vascular surgery has been advocated to reduce clamping 
time of the artery, reduce intimal hyperplasia, due to the non-penetrating characteristics of 
the clips, and increase patency rates. 4 However, little was known on the use of clips on the 
femoral artery. We therefore conducted this pilot study, to assess the safety of the clips on the 
proximal anastomosis in peripheral vascular surgery. We included patients after both periph-
eral bypass surgery as well as after femoral endarterectomies, because we assumed that the 
technique of applying an anastomosis at the femoral artery, would not differ between both 
procedures. At least for our outcomes of anastomosis speed and patient safety. We are aware 
that patency rates between both procedures are not very comparable.
The time needed for applying the anastomoses was not significantly different from the 
control group. Our preliminary results did not meet our expectations. Although the initial 
technical success rate was high, significant complications occurred in the VCS group that 
could be attributed to the use of clips. There were two serious adverse events in the VCS 
group; in one patient the clipped anastomosis ruptured, causing  major bleeding from the 
femoral artery. In another patient an acute thrombosis of the superficial femoral artery had 
occurred. As we could not determine any benefits from the use of clips in the proximal anas-
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tomosis, we concluded the safety of the use of VCS clips in peripheral vascular surgery is not 
proven, and we will not continue with a large randomized control trial.
chapter 4 shows the results of a review, conducted on QoL in peripheral vascular surgery. 
On short term follow-up, all interventions resulted in increased QoL scores. However, on 
long term follow-up very little is known. Only one study assessed QoL on real long term, and 
showed a decrease in QoL scores5. However, as long term follow-up results in high number of 
lost to follow up, the long term effect of intervention in vascular surgery remains uncertain.
Another problem is the use of different questionnaires, which makes it hard to compare 
results between studies. Most importantly, many studies use health status questionnaires, 
instead of QoL questionnaires. This can make the interpretation and comparison of their 
results very difficult as health status does not necessarily relates to QoL.6
In chapter 5 the results for QoL on midterm follow-up after peripheral bypass surgery are 
presented.  An important result in our study is that the increase in short term QoL on the 
physical domain in patients who underwent peripheral bypass surgery is not consistent after 
a mean follow-up of 33 months. The results found with our last questionnaire showed no 
significant change compared to baseline QoL scores. It seems that the gained increase in QoL 
after bypass surgery is of a temporarily nature. This study was part of a RCT comparing pneu-
matic compression (IPC) with compression stockings (CS) for both autologous peripheral 
bypass grafting and PTFE bypass grafting. As in autologous bypass grafting the long-term 
results (90 days) of IPC vs CS shows no significant difference 7, and in PTFE bypass grafting 
no significant difference between IPC and CS were found at all. 8 We are convinced that 
there is no influence of IPC vs Cs on long-term QoL or survival. Analyzing treatment effect 
on QoL in PAD patients is hard to establish. As PAD is multifactorial, and occurs mostly in the 
elderly patients, co-morbidities have a large influence on the QoL scores, both before, and 
after treatment. As showed a study by Breek9, not only the walking limitation affects the QoL 
scores of PAD patients. Cardiovascular co-mobidities, as well as other leg problems (eg lower 
back, hip or knee problems) have a significant influence on QoL scores. In our new designed, 
prospective study on QoL scores in the elderly PAD population, patients are classified by use 
of the Possum score.
Three-year mortality rates were 25% for autologous bypass grafts and 46% for PTFE grafts, 
overall three-year mortality rate was 33% for both groups combined. A Cox proportional 
hazard survival analysis, stratified by bypass graft type, did not show a significant effect of 
treatment: the mortality rate ratio of IPC to CS was 1.07 (95 % CI: 0.52-2.20; p = 0.86), adjusted 
for age and gender.  Only the effect of age was significant: the mortality rate increases by 
8 % per year of age at baseline (95 % CI: 2.9-13.3 %; p = 0.002). Taking graft bypass type as 
explanatory variable in an unstratified Cox-regression along with treatment, age and gender 
resulted in a non-significant mortality rate ratio of PTFE to autologous of 1.51 (95 % CI: 0.73-
3.12; p = 0.27).
Such survival rates are not unusual as recently reported by Bradbury et al.10
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chapter 6 shows our results on the introduction of Vascular Nurse Practitioners (NPs) in 
relation to patients QoL scores, anxiety and depression scores. Thus far are no reports avail-
able about QoL, anxiety and depressive symptom scores in patients treated and guided by 
a (vascular) NP. In this study the goal was to establish whether NPs would influence patient 
oriented outcome measurements differently than vascular surgeons themselves.
QoL on the physical domain did increase in both groups after treatment while anxiety 
scores significantly decreased after treatment. However no differences between both groups 
were found.
The increased QoL on the physical domain, was about 5 points. This is in concordance with 
previously performed studies on QoL after bypass surgery, in which a short term QoL results 
were investigated. 11 It seems to be quite difficult to assess the actual benefits of adding NPs 
to an existing care team.
In chapter 7 our results for registering surgical complications are presented. The mean 
outcome of this investigation is that surgical site infections are scored more reliable by infec-
tion control nurses than by medical doctors. The missed infections in the vascular database 
occurred almost all after the patient’s discharge. However, every patient with a surgical site 
infection, which was not recorded in the vascular database, was admitted to the hospital 
again, and received the appropriate care.
As most surgical site infections occurred after patients discharge, especially the outer-
patient-clinic registration is unreliable. A possible improvement for this problem, could be 
assigning a specially trained data-manager, to register all complications in a database.
Surgical site infection after vascular surgery is a frequent complication associated with 
increased morbidity and significant additional costs 12-23. Therefore adequate registration is 
necessary, so evaluation in time is adequate and reliable.
As more states in the United States of America are mandatory in reporting their Healthcare 
associated infections 24, the reliability of the used registration method is becoming more and 
more important.
When in one hospital, in one surgical department, two different registrations methods 
produce such different values, it is clear that published results are more dependent on the 
type of registration, than they are on the quality of healthcare.
Best result will be obtained when surgeons and the department of Microbiology and Infec-
tion prevention work together in identifying and registering all surgical site infections.
Our center now uses a scheduled meeting with a vascular surgeon, a medical microbiologists 
and a trained infection control nurse. Here every possible surgical site infection is discussed 
and registered, to produce a reliable database.
In chapter 8 we analyzed the effect of S. aureus nasal carriage on the incidence of surgical 
site infections with this pathogen. The outcomes were; the majority of SSI’s are caused by S. 
aureus, and that, at least for central reconstructions, there is an increased risk for occurrence 
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of S. aureus based SSI’s in positive carriers. The effect in this group is comparable to what has 
been found previously in cardiothoracic and orthopedic surgery.25-28
Based on the results of this study we conclude that S. aureus carriers who undergo central 
reconstructive surgery have a significant higher risk for the development of SSI which can be 
decreased by perioperative eradication of S. aureus in nasal carriers.29
This is important because infection with S. aureus after aortic reconstructions is related to 
severe complications and a high mortality rate.
conclusions
Chapter 2 In patients without a suitable ASV (or other vein), the pre-cuffed PTFE bypass graft 
is a reasonable alternative, which results in an acceptable limb salvage rate.
Chapter 3 The VCS clip system has not proven its safety on anastomoses on the femoral artery.
Chapter 4 Little is known on Long Term follow-up QoL after vascular intervention. Random-
ized studies are required to provide definitive evidence of the true benefit of intervention in 
patients with PAD.
Chapter 5 Although peripheral bypass surgery significantly increases QoL at 2 short term 
follow-up, this is lost after > 2 years of follow-up. Therefore, there is no midterm increased 
QoL benefit after bypass surgery. Quality of Life as outcome (at least at > 2 years of follow-
up), seems to have no relation with classical outcome measurements, such as graft patency, 
mortality and limb-salvage.
Chapter 6 Vascular NPs, at least for patients’ QoL, anxiety and depression scores, perform 
equally to the vascular surgeons. This shows that they are capable of explaining intervention 
procedures to patients, and their guidance through treatment is comparable to those of 
vascular surgeons. Therefore NPs can lower the vascular surgeons workload and lower costs 
at the same time, without losing quality of care.
Chapter 7 A reliable complication registration is very important on improving quality of care. 
However, trained data managers produce a more reliable database in comparison to medical 
doctors.
Chapter 8 Pre-operatively eradicating nasal carriage of S. aureus in patients who have to 
undergo central reconstructive surgery may decrease the number of surgical site infections 
in this population. Thereby lowering patients morbidity and costs.
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Gezien de incidentie van perifeer arterieel vaatlijden (PAV) toeneemt1, 2 en er steeds meer 
nieuwe technieken worden ontwikkeld voor de behandeling van vaatlijden op minimaal 
invasieve manieren is de rol van de chirurgische interventies aan het veranderen. Als aanvul-
ling op de klassieke uitkomstmaten, zoals patency en limb salvage, is er ook steeds meer 
aandacht voor nieuwe, patiëntgebonden uitkomsten.
Daarnaast zijn ook de chirurgische interventies aan doorontwikkeling onderhevig.
Zo blijven er doorontwikkelingen verschijnen van de distale anastomoses van kunststof 
bypasses en is er aandacht voor nieuwe technieken bij het aanleggen van de proximale 
anastomoses.
hoofdstuk 2 toont onze resultaten van een vergelijkende studie naar de nieuw ontwik-
kelde kunststof bypass, met een voorgevormde distal cuff. Ondanks deze cuff, blijken de 
patency waarden van de autologe bypasses, zeker voor aansluiting onder het niveau van de 
knie, significant beter. Concluderend blijft de autologe bypass nog steeds de techniek van 
eerste keus bij perifere bypass chirurgie. Daarentegen is bij patiënten die geen geschikte 
vene hebben voor een autologe bypass, de kunststof bypass met voorgevormde cuff een 
redelijk alternatief. Zeker op het gebied van limb salvage. Naast de kunststof bypasses met 
een cuff, zijn er ook kunststof bypasses met een speciale Heparine coating. Wanneer we onze 
resultaten vergelijken met een studie naar de Heparine gecoate bypasses, blijken de laatste 
mogelijk tot betere patency waardes te resulteren.
Een studie door Daenens laat indrukwekkende patency waardes zien voor een Heparine 
gecoate bypass3, maar aangezien in deze studie erg weinig autologe bypass operaties zijn 
verricht, maakt het 1 op 1 vergelijken van onze resultaten lastig. Om met zekerheid uit te 
zoeken welke kunststof bypass superieur is in patiënten met PAV is een prospectieve, geran-
domiseerde studie nodig.
In hoofdstuk 3 wordt een nieuwe techniek beschreven voor het aanleggen van de proxi-
male anastomose in perifere vaatchirurgie. Het gebruik van niet penetrerende, titanium clips 
zou zorgen voor kortere tijdsduur voor het aanleggen van de anastomose en daardoor zor-
gen voor een kortere klem tijd, tevens zouden de clips het optreden van intima hyperplasie 
moeten reduceren en daardoor de patency waarden verhogen.4 Echter voor het gebruik van 
deze clips op de femoraal arteriën is weinig bekend. Daarom is een haalbaarheidsstudie ver-
richt om te beoordelen of de clips op de femoraal arteriën veilig te gebruiken zijn.
In een studieverband werd een klein aantal patiënten gerandomiseerd voor het aanleggen 
van de anastomose middels clips. Het ging om zowel perifere bypass operaties, alsmede 
endarteriectomiën van de femoraal arteriën. Hiervoor is gekozen omdat de techniek middels 
clips in beide groepen goed vergelijkbaar is, ondanks het verschil in patency waardes tus-
sen beide procedures. Er was geen significant verschil in de snelheid van het aanleggen van 
de anastomoses. Daarnaast bleken de clips, hoewel het technische resultaat per operatief 
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goed was, op langere termijn toch tekortkomingen hadden. In de clip groep traden twee 
ernstige complicaties op, doortoedoen van de clips. In één patiënt scheurde post operatief 
de anastomose uit, resulterend in een bloeding uit de femoraal arterie. Bij een andere patiënt 
trad een acute occlusie op van de aangelegde anastomose, door een niet gefixeerde intima 
flap. Beide patiënten hadden acuut een her operatie nodig. Gezien deze resultaten durven 
we de veiligheid van de clips op de femoraal arteriën niet te garanderen. Als gevolg hiervan 
zal er geen groot gerandomiseerd onderzoek worden opgezet.
hoofdstuk 4 beschrijft de resultaten van een review naar de literatuur betreffende de Kwa-
liteit van Leven (KvL) na interventies vanwege PAV. Op korte termijn resulteren alle interven-
ties naar een stijging van KvL, maar over lange termijn resultaten blijkt weinig bekend te zijn. 
Slechts één grote studie analyseerde de lange termijnresultaten voor KvL na perifere bypass 
chirurgie, en laat dalende KvL waardes zien.5 Aangezien het na lange termijn analyseren van 
KvL in oudere patiënten tevens zorgt voor een grote hoeveelheid uitvallende deelnemers, 
zijn de resultaten moeilijk te interpreteren. Er blijft veel onduidelijkheid over de lange termijn 
resultaten naar KvL in PaV.
Daarnaast is ook de grote diversiteit tussen verschillende vragenlijsten naar KvL een pro-
bleem om resultaten van verschillende onderzoeken goed te vergelijken.
Daarnaast blijken veel studies vragenlijsten te gebruiken die een gezondheidstoestand 
analyseren en geen KvL. Dit maakt interpretatie van deze resultaten erg lastig en vergelijking 
tussen studies bijna onmogelijk, aangezien gezondheidstoestand scores niet gerelateerd 
kunnen lijken te worden aan KvL scores.6
In hoofdstuk 5 presenteren wij onze resultaten naar KvL op de middellange duur na 
perifere bypass chirurgie. Een belangrijke uitkomst is dat de op korte termijn verhoogde 
KvL, op de middellange duur niet meer detecteerbaar is. De gevonden KvL waardes bij ons 
laatste meetmoment laten geen significant verschil meer zien met de waardes bij start van 
de studie. Het blijkt dat de toegenomen KvL waarden na perifere bypass chirurgie slechts van 
korte duur is. Deze studie was onderdeel van een gerandomiseerde trial naar het effect van 
een voetpomp, in vergelijking met steunkousen, ter behandeling van post operatief oedeem 
na bypasschirurgie. Aangezien de resultaten van voetpomp behandeling na autologe bypass 
operatie geen verschil laten zien na 90 dagen7 en in de kunststof groep überhaupt geen 
verschil tussen beide behandelingen is aangetoond 8 zijn we ervan overtuigd dat zowel 
de voetpomp behandeling, als de steunkous behandeling geen invloed heeft op de KvL of 
overleving. Het bestuderen van een behandelingseffect op KvL, is zeker voor patiënten met 
PaV lastig te onderzoeken op de lange termijn. Het ziektebeeld is multifactorieel, en treft 
over het algemeen de oudere patiënten, die een uitgebreide comorbiditeit kunnen hebben.
Zoals aangetoond is in een onderzoek van Breek9, hebben niet alleen belemmeringen van 
PaV invloed op de KvL, maar ook is er een significante invloed van andere ziektebeelden die 
deze patiëntengroep vaak heeft (zoals gewrichtsproblemen). Daarnaast blijken ook cardio-
vasculaire comorbiditeit een significante invloed te hebben op de KvL waardes van patiënten 
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met PaV. In een nieuwe studie naar KvL voor oudere patiënten lijdend aan PaV, die onlangs 
door ons is opgezet, zullen we hiervoor patiënten classificeren middels de Possum score. 
De drie-jaars mortaliteit was 25% voor patiënten die een autologe bypass operatie hadden 
ondergaan, en 46% voor patiënten na een kunststof bypass operatie.
De gemiddelde drie-jaars mortaliteit was 33% voor beide groepen samen. Een multivariate 
analyse toonde alleen een significante invloed van hogere leeftijd op de mortaliteit. Er werd 
geen significant verschil aangetoond op basis van bypass type. Overlevings en mortaliteit 
cijfers als deze zijn niet ongebruikelijk, gezien de uitkomsten van Bradburry.10
hoofdstuk 6 toont de resultaten van ons onderzoek naar de invloed van de invoering van 
Nurse Practitioners, op patiënt scores voor KvL, angst en depressie. Tot nu toe waren hierover 
geen onderzoeken beschreven. In deze studie was het doel om aan te tonen welke invloed 
de invoering van NP’s had op patiëntgebonden uitkomstmaten. De KvL verbeterde in beide 
groepen na behandeling, de angst en depressie scores verminderde na behandeling. Echter 
tussen beide groepen kon geen significant verschil worden aangetoond.
Op het fysieke domein, steeg de KvL met ongeveer 5 punten, dit is in overeenstemming 
met eerder gepubliceerde artikelen naar de invloed van behandeling van PaV op KvL scores 
op korte termijn.11 Het blijkt erg lastig te zijn, om de toegevoegde waarde van NP’s aan een 
behandelteam te bewijzen.
In hoofdstuk 7 worden de resultaten gepresenteerd van een studie naar de registratie 
van complicaties. De belangrijkste uitkomst is dat artsen complicaties minder nauwkeurig 
registreren als speciaal getrainde buitenstaanders. De meest gemiste complicaties traden op 
na het ontslag van patiënten. Echter, elke patiënt die na ontslag een wondinfectie kreeg, was 
hiervoor wel behandeld op de polikliniek of op de spoed eisende hulp. Het probleem is niet 
het missen of onderkennen van het optreden van een complicatie, maar het registreren van 
deze complicatie. Met name in de poliklinische setting, blijkt dat de registratie onbetrouw-
baar is. Wij menen dat met de toevoeging van speciaal getrainde personen, die als taak heb-
ben om complicaties te registreren en analyseren, dit probleem kan worden ondervangen. 
Het optreden van complicaties, met name post operatieve wondinfecties, is geassocieerd 
met toegenomen morbiditeit en extra kosten12-23.
Hierom is een adequate registratie noodzakelijk, om zo de kwaliteit van zorg te bewaken, 
en veranderingen in tijd aan het licht te stellen. Met de toegenomen druk, mede vanuit 
overheden en zorgverzekeringen om complicatie cijfers te openbaren, is een betrouwbare 
registratie van het allergrootste belang. Wanneer in één ziekenhuis, twee verschillende regi-
stratie databases een dusdanig verschil tonen, is de vraag wat de betrouwbaarheid zal zijn, 
wanneer cijfers tussen verschillende ziekenhuizen worden vergeleken.
De meest betrouwbare registratie van post operatieve wondinfecties kan worden verkre-
gen, wanneer de afdelingen heelkunde en medische microbiologie gaan samenwerken aan 
de registratie.
122
Discussie en samenvatting
In ons ziekenhuis is nu een multidisciplinair overleg ingesteld, waarin zowel een vaat-
chirurg, als een medisch microbioloog en een adviseur infectie preventie gezamenlijk de 
registratie van post operatieve wondinfecties voor de vaatchirurgie documenteren. Op deze 
wijze menen wij een betrouwbare registratie database te kunnen opzetten voor post opera-
tieve wondinfecties na vaatchirurgie.
In hoofdstuk 8 werd de relatie bestudeerd tussen neusdragerschap van S aureus en het 
optreden van wondinfecties met deze bacterie na vaatchirurgie. De belangrijkste uitkomsten 
waren; de meerderheid van alle wondinfecties na vaatchirurgie wordt veroorzaakt door de 
S. aureus. Daarnaast is voor in ieder geval centrale vaatoperaties een significant hoger risico 
op het ontwikkelen van een post operatieve wondinfectie voor patiënten met een positief 
neusdragerschap. Deze relatie komt overeen met de eerder gevonden relatie binnen de 
cardiothoracale chirurgie en de orthopedische chirurgie.24-27
Gebaseerd op deze resultaten concluderen wij dat dragers van een S. aureus die een cen-
trale vaatoperatie moeten ondergaan een significant hoger risico hebben op het ontwikkelen 
van een post operatieve wondinfectie. Dit verhoogde risico zou mogelijk kunnen worden 
verlaagd met een preoperatieve eradicatie van het dragerschap.28
Dit is een belangrijke uitkomstmaat gezien wondinfecties met een S aureus na centrale 
vaatoperaties zijn gerelateerd aan ernstige complicaties en een toegenomen mortaliteit.
conclusies
Hoofdstuk 2 Voor patiënten die geen geschikte vene hebben om als bypass te dienen, vormt 
de kunststof bypass met voorgevormde cuff een redelijk alternatief gezien de limb salvage 
resultaten.
Hoofdstuk 3 Het VCS clip system heeft niet kunnen overtuigen dat het veilig gebruikt kan 
worden bij anastomoseringen op de femoraal arteriën.
Hoofdstuk 4 Voor de lange termijnresultaten is er weinig bekend over de KvL in PaV. 
Prospectieve, gerandomiseerde studies zijn nodig om eenduidig bewijs te leveren naar KvL 
in PaV.
Hoofdstuk 5 Ondanks dat perifere bypass chirurgie op de korte termijn resulteert in 
toegenomen KvL, is dit effect na >2 jaar niet meer aan te tonen. KvL lijkt geen relatie te heb-
ben met de klassieke uitkomst maten, als patency en limbsalvage.
Hoofdstuk 6 Nurse practitioners hebben geen invloed op de KvL, angst en depressie scores 
van patiënten met PaV. De begeleiding en uitleg, gegeven door NP’s stellen patiënten even-
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veel gerust, als die van de vaatchirurgen zelf. Hiermee kan de toevoeging van NP’s aan het 
behandelteam de werklasten van de chirurg verminderen, zonder aan kwaliteit van zorg in 
te leveren.
Hoofdstuk 7 Om de kwaliteit van zorg te verbeteren is een betrouwbare complicatiereg-
istratie van groot belang. Echter levert een speciaal getraind, onafhankelijk persoon een 
betrouwbare registratie op, in vergelijking met artsen zelf.
Hoofdstuk 8 Preoperatief eradicatie therapie voor neusdragerschap van S. aureus bij 
patiënten die een centrale vaatoperatie moeten ondergaan kan mogelijk het aantal postop-
eratieve wondinfecties verminderen. Daarbij zullen de morbiditeit, evenals de kosten van de 
gezondheidszorg afnemen.
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